Expression of human pro-matrix metalloproteinase 3 that lacks the N-terminal 34 residues in Escherichia coli:: Autoactivation and interaction with tissue inhibitor of metalloproteinase 1 (TIMP-1)

被引:49
作者
Suzuki, K
Kan, CC
Hung, W
Gehring, MR
Brew, K
Nagase, H
机构
[1] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA
[2] Agouron Pharmaceut Inc, San Diego, CA 92121 USA
[3] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA
关键词
extracellular matrix; stromelysin; TIMP; zymogen activation;
D O I
10.1515/bchm.1998.379.2.185
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human pro-matrix metalloproteinase 3 (proMMP-3) tacking the N-terminal 34 amino acids and the C-terminal hemopexin-like domain was expressed in E. coli and used to investigate the process of proenzyme activation and its interaction with an endogenous inhibitor TIMP-1 during activation. The truncated precursor was purified from the E. coli extract in the presence of 5mM EGTA. The active 23.5 kDa form was generated simply by exposure to Ca2+ and Zn2+ but not either by Ca2+ alone or by Zn2+ alone. The rate of MMP-3(Delta C) formation was concentration dependent, indicating that autoactivation is a bimolecular reaction. The truncated precursor was able to interact with the N-terminal domain of TIMP-1 without losing the 48 residue-long propeptide. However, upon a longer incubation, the propeptide was slowly processed, indicating that the association of the N-terminally truncated proMMP-3 with TIMP-1 is weaker than that of the fully activated MMP-3 and TIMP-1. These results indicate that the expression of MMP activities is regulated by endogenous inhibitor TIMPs during their activation processes which provide an additional control mechanism of extracellular matrix breakdown.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 35 条
  • [1] STROMELYSIN-1 - 3-DIMENSIONAL STRUCTURE OF THE INHIBITED CATALYTIC DOMAIN AND OF THE C-TRUNCATED PROENZYME
    BECKER, JW
    MARCY, AI
    ROKOSZ, LL
    AXEL, MG
    BURBAUM, JJ
    FITZGERALD, PMD
    CAMERON, PM
    ESSER, CK
    HAGMANN, WK
    HERMES, JD
    SPRINGER, JP
    [J]. PROTEIN SCIENCE, 1995, 4 (10) : 1966 - 1976
  • [2] Characterization of the 46-kDa intermediates of matrix metalloproteinase 3 (stromelysin 1) obtained by site-directed mutation of phenylalanine 83
    Benbow, U
    Buttice, G
    Nagase, H
    Kurkinen, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (18) : 10715 - 10722
  • [3] Use of an active-site inhibitor of stromelysin to elucidate the mechanism of prostromelysin activation
    Cameron, PM
    Marcy, AI
    Rokosz, LL
    Hermes, JD
    [J]. BIOORGANIC CHEMISTRY, 1995, 23 (04) : 415 - 426
  • [4] DISRUPTION OF THE CYSTEINE-75 AND ZINC ION COORDINATION IS NOT SUFFICIENT TO ACTIVATE THE PRECURSOR OF HUMAN MATRIX METALLOPROTEINASE-3 (STROMELYSIN-1)
    CHEN, LC
    NOELKEN, ME
    NAGASE, H
    [J]. BIOCHEMISTRY, 1993, 32 (39) : 10289 - 10295
  • [5] RECIPROCATED MATRIX METALLOPROTEINASE ACTIVATION - A PROCESS PERFORMED BY INTERSTITIAL COLLAGENASE AND PROGELATINASE-A
    CRABBE, T
    OCONNELL, JP
    SMITH, BJ
    DOCHERTY, AJP
    [J]. BIOCHEMISTRY, 1994, 33 (48) : 14419 - 14425
  • [6] DECLERCK YA, 1991, J BIOL CHEM, V266, P3893
  • [7] FREIMARK BD, 1994, J BIOL CHEM, V269, P26982
  • [8] APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide
    Galazka, G
    Windsor, LJ
    BirkedalHansen, H
    Engler, JA
    [J]. BIOCHEMISTRY, 1996, 35 (34) : 11221 - 11227
  • [9] EXAFS EVIDENCE FOR A CYSTEINE SWITCH IN THE ACTIVATION OF PROSTROMELYSIN
    HOLZ, RC
    SALOWE, SP
    SMITH, CK
    CUCA, GC
    QUE, L
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (24) : 9611 - 9614
  • [10] Hooper N.M., 1996, Zinc Metalloproteases in Health and Disease, P153